Moleculin Biotech Inc (MBRX)

Finanzdaten der Moleculin Biotech Inc-Aktie (MBRX)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	25.14% 6.677	8.919	5.947	6.411	8.354
Operating Income/Loss	25.14% -6.677	-8.919	-5.947	-6.411	-8.354
Income/Loss From Continuing Operations Before Tax	51.60% -4.97	-10.27	-5.609	-5.976	-7.915
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	51.60% -4.97	-10.27	-5.609	-5.976	-7.915
Net Income/Loss	51.60% -4.97	-10.27	-5.609	-5.976	-7.915
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	108.99% 2.4662	-27.44	29.81	29.69	28.75
Basic Earnings Per Share	85.98% -2.02	-14.41	-0.19	-0.20	-0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-